Middle East & Africa Transfection Reagents & Equipment Market Size & Outlook
Middle East & Africa transfection reagents & equipment market, 2016-2028 (US$M)
Related Markets
MEA transfection reagents & equipment market highlights
- The MEA transfection reagents & equipment market generated a revenue of USD 28.5 million in 2020.
- The market is expected to grow at a CAGR of 9.4% from 2021 to 2028.
- In terms of segment, equipment was the largest revenue generating product in 2020.
- Equipment is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2021 to 2028.
MEA data book summary
| Market revenue in 2020 | USD 28.5 million |
| Market revenue in 2028 | USD 58.7 million |
| Growth rate | 9.4% (CAGR from 2020 to 2028) |
| Largest segment | Equipment |
| Fastest growing segment | Equipment |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Equipment |
| Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Qiagen NV, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Merck KGaA, Origin Enterprises PLC, MaxCyte Inc, PromoCell GmbH, Promega, Polyplus-transfection, Horizon Discovery |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.9% of the global transfection reagents & equipment market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 412.0 million by 2028.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transfection Reagents & Equipment Market Scope
Transfection Reagents & Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa transfection reagents & equipment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transfection reagents & equipment market will help companies and investors design strategic landscapes.
Equipment was the largest segment with a revenue share of 51.93% in 2020. Horizon Databook has segmented the Middle East & Africa transfection reagents & equipment market based on reagents, equipment covering the revenue growth of each sub-segment from 2016 to 2028.
Rising demand for gene therapy and evolving drug development industry are the two key factors contributing to growth of transfection reagents and equipment market in this region. As per a study released in the 3rd Annual Congress on Rare Diseases and Orphan Drugs, the Middle East is expected to offer significant profitable opportunities pertaining to orphan drug development.
Increasing incidence of rare disorders has made patient recruitment less challenging, with respect to orphan drug clinical development. Transfection has witnessed wide acceptance across orphan drug development in recent years, which is expected to propel the demand for transfection reagents and technologies across the region.
Reasons to subscribe to Middle East & Africa transfection reagents & equipment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa transfection reagents & equipment market databook
-
Our clientele includes a mix of transfection reagents & equipment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa transfection reagents & equipment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa transfection reagents & equipment market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
MEA transfection reagents & equipment market size, by country, 2016-2028 (US$M)
Middle East & Africa Transfection Reagents & Equipment Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
